Preview Mode Links will not work in preview mode

Sep 26, 2022

Featuring a slide presentation and related discussion from Dr Heather Wakelee, including the following topics:

  • Key efficacy and safety data with belantamab mafodotin for multiple myeloma (MM) (0:00)
  • Guidelines for the prevention and management of keratopathy in patients receiving belantamab mafodotin (3:46)
  • Belantamab mafodotin in combination with pomalidomide; recent data and ongoing trials with BCMA-targeted bispecific antibodies (7:30)
  • BCMA-targeted CAR (chimeric antigen receptor) T-cell therapies under evaluation for MM (17:07)

CME information and select publications